Prot #MKC‐TI‐193: INHALE‐3: A 17‐Week Randomized Trial and a 13‐Week Extension, Evaluating theEfficacy and Safety of Inhaled Insulin (Afrezza®) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes

Project: Research project

Project Details

StatusActive
Effective start/end date7/28/237/28/26

Funding

  • Jaeb Center for Health Research (Prot #MKC-TI-193 // Prot #MKC-TI-193)
  • MannKind Corporation (Prot #MKC-TI-193 // Prot #MKC-TI-193)